SIRT3 and neuropathic pain: These findings identify SIRT3 as a critical regulator of microglial-mediated oxidative stress and inflammatory responses, establishing a mechanistic link between BHB-dependent effects and the therapeutic efficacy of the KD in neuropathic pain.